We are live on ! Find out more
SSG

Summit Securities Group Portfolio holdings

AUM $810M
1-Year Est. Return 27.35%
This Fund
S&P 500
This Quarter Est. Return
-16.05%
1 Year Est. Return
+27.35%
3 Year Est. Return
+96.65%
5 Year Est. Return
+169.28%
10 Year Est. Return
+1,327.37%
AUM
$569M
AUM Growth
-$753M
Cap. Flow
-$641M
Cap. Flow %
-112.75%
Top 10 Hldgs %
29.13%
Holding
545
New
123
Increased
51
Reduced
96
Closed
266

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$66.3M
2
MSFT icon
Microsoft
MSFT
+$43M
3
WDC icon
Western Digital
WDC
+$30.4M
4
DIS icon
Walt Disney
DIS
+$18.9M
5
USB icon
US Bancorp
USB
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 4.99%
2 Technology 4.97%
3 Financials 2.92%
4 Communication Services 2.11%
5 Consumer Staples 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
501
Weyerhaeuser
WY
$17.3B
-11,500
Closed -$347K
XLF icon
502
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
-243,700
Closed -$6.71M
XLF icon
503
PUT
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
-583
Closed -$1.79M
XLK icon
504
State Street Technology Select Sector SPDR ETF
XLK
$115B
-24,400
Closed -$1.12M
XLP icon
505
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
-27,700
Closed -$1.75M
XLU icon
506
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
-10,400
Closed -$336K
XLV icon
507
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
-24,700
Closed -$2.52M
XOP icon
508
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
-150
Closed -$1.43M
XRX icon
509
Xerox
XRX
$337M
-6,800
Closed -$251K
TVRD
510
CALL
Tvardi Therapeutics
TVRD
$23.5M
-8
Closed -$461K
ITCI
511
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-100
Closed -$343K
ITCI
512
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-3,500
Closed -$12M
PXD
513
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
-20
Closed -$303K
PXD
514
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
-20
Closed -$303K
VMW
515
PUT
DELISTED
VMware, Inc
VMW
-150
Closed -$2.28M
MMP
516
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
-200
Closed -$1.26M
RSX
517
DELISTED
VanEck Russia ETF
RSX
-40,500
Closed -$1.01M
RSX
518
PUT
DELISTED
VanEck Russia ETF
RSX
-101
Closed -$252K
ZNGA
519
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-300
Closed -$184K
FOE
520
DELISTED
Ferro Corporation
FOE
-10,000
Closed -$148K
BPY
521
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
-13,900
Closed -$254K
CXO
522
CALL
DELISTED
CONCHO RESOURCES INC.
CXO
-830
Closed -$7.27M
CXO
523
DELISTED
CONCHO RESOURCES INC.
CXO
-8,300
Closed -$727K
FIT
524
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
-1,350
Closed -$887K
TIF
525
DELISTED
Tiffany & Co.
TIF
-7,200
Closed -$947K

Similar funds

Summit Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Summit Securities Group held 545 positions worth $569M, down 57% from $1.32B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Summit Securities Group withdrew a net $641M in Q1 2020, closing 266 positions and reducing 96 holdings. Its most notable exit was US Bancorp, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 4% a quarter earlier, followed by Technology and Financials.

Against the trend, Summit Securities Group opened a new position in Takeda Pharmaceutical worth $3.87M.

  • Summit Securities Group's largest Q1 2020 buy was Takeda Pharmaceutical: 254,651 shares worth $3.87M.
  • Summit Securities Group added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2020, an estimated $25M increase.
  • Summit Securities Group's biggest Q1 2020 reduction was Apple, cutting an estimated $66.3M.
  • Summit Securities Group fully exited US Bancorp in Q1 2020, selling an estimated $14.4M.
  • Summit Securities Group's ten largest holdings make up 29% of its $569M portfolio in Q1 2020.
  • Summit Securities Group opened 123 new positions and closed 266 in Q1 2020.
  • Summit Securities Group's portfolio value fell 57% quarter-over-quarter to $569M.

Based on Summit Securities Group's 13F filing for Q1 2020, filed 28 Apr 2020.